FDA engages pharmaceutical industry players over essential drugs

By Julius K. Satsi, GNA 

Accra, March 26, GNA – The Food and Drugs Authority
(FDA) has met with stakeholders of the Pharmaceutical Industry and assured them
of fast tracking the approval for the production of essential drugs, including
chloroquine, which are needed for the case management of  COVID-19.

The stakeholders, however, gave the assurance that the
industry had the capacity to produce the selected drugs and that the current
stocks of locally manufactured and imported medicines were adequate to cater
for the COVID-19 pandemic for the next three months.

In an interview with the Ghana News Agency on Thursday, Mr
James Lartey, the Head of Communications Department, said the Authority would,
however, not compromise the quality, safety and efficacy of any drug, as seen
in the approval for hand sanitisers.

The proposed drugs for treatment for COVID-19 include
hydroxychloroquine and chloroquine; and Remdesivir. 

Hydroxychloroquine and chloroquine are oral prescription
drugs that have been used for treatment of malaria and certain inflammatory
conditions.

Chloroquine has also been used for malaria treatment and
chemoprophylaxis; while hydroxychloroquine is used for treatment of rheumatoid
arthritis, systemic lupus erythematosus and porphyria cutanea tarda. 

“Remdesivir is an investigational intravenous drug with broad
antiviral activity that inhibits viral replication through the premature
termination of RNA transcription and has in-vitro activity against SARS-CoV-2
and in-vitro and in-vivo activity against related beta coronaviruses,” the FDA
explained. 

“It is necessary to establish the current stocks of essential
medicines, both finished products and raw materials, the capacity of the local
manufacturers to meet the needs of the country to help the Ministry of Health
in planning to avert any shortages and stock outs.

The meeting was also used to solicit support from the
industry to fight the pandemic. 

Mrs Delese Darko, the Chief Executive Officer (CEO), led a
team of FDA Officers during the engagement.

The stakeholders included the Chamber of Pharmacy,
Pharmaceutical Manufacturers Association of Ghana (PMAG), Pharmaceutical
Importers and Wholesalers Association (PIWA), Community Practice Pharmacists
Association (CPPA), and Small Scale Pharmaceuticals Manufacturers Association.
  

Part of the FDA’s function is to advise the Minister of
Health on measures for the protection of consumer wellbeing.

The industry players, however, urged the Government to supply
the requisite guarantees to enable them to secure financial support from the
banks to produce the needed essentials drugs. 

It should also consider making provision for Personal
Protective Equipment (PPE) to Community Pharmacists and Over-the-Counter
Medicine Sellers who were the first-line of call for most consumers.

GNA

Loading...